JENNIFER BUTLER ACUFF: Open Payments
NPI 1609910355 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 38 payments from 12 companies in 2025. Trend: 2023 $208 · 2024 $167 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $265 |
| Regeneron Healthcare Solutions, Inc. | 8 | $155 |
| Amgen Inc. | 5 | $100 |
| Octapharma USA, Inc. | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Genentech USA, Inc. | 2 | $31 |
| Ionis Pharmaceuticals, Inc. | 1 | $27 |
| GC Biopharma USA, Inc. | 1 | $24 |
| CSL Behring | 1 | $22 |
Products named: TEZSPIRE, DUPIXENT, AIRSUPRA, GLASSIA, PANZYGA, Xolair, FASENRA, ALYGLO.
Industry payments across AL — which companies pay providers there.
